Clinical Trial Update: Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma [NA]

View source ↗

Summary

A completed preclinical study using tumor replicates in an avian embryo to model the effects of BRAF inhibitors and MEK inhibitors in BRAF-mutated melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BRAF inhibitors (BRAF inhibitor)
• MEK inhibitors (MEK inhibitor)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Melanoma | NA | Status: COMPLETED